Aligos Therapeutics (ALGS) EBITDA Margin Growth (5y) (2026)

Aligos Therapeutics (ALGS) EBITDA Margin Growth (5y) (2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.93 Bn	131.07 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.91 Bn	77.92 Bn	3.93 Bn
3	Argenx Se	64.98 Bn	59.80 Bn	1.37 Bn
4	Moderna	58.86 Bn	53.72 Bn	52.00 Mn
5	BeOne Medicines	42.03 Bn	36.93 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.54 Bn	28.23 Bn	992.69 Mn
7	BioNTech SE	27.88 Bn	9.49 Bn	668.28 Mn
8	Insmed	27.44 Bn	26.28 Bn	358.27 Mn
9	Royalty Pharma	27.35 Bn	26.51 Bn	-
10	Aligos Therapeutics	69.26 Mn	38.82 Mn	-

Download Data

Date	Value
Mar 31, 2026	209,680.00